Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.75p
   
  • Change Today:
    -4.75p
  • 52 Week High: 82.00
  • 52 Week Low: 13.20
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 6,683,242
  • Market Cap: £15.96m
  • RiskGrade: 410

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average
Price Chg 3m
97.74% below the market average97.74% below the market average97.74% below the market average97.74% below the market average97.74% below the market average
96.49% below the sector average96.49% below the sector average96.49% below the sector average96.49% below the sector average96.49% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
58.32% below the market average58.32% below the market average58.32% below the market average58.32% below the market average58.32% below the market average
62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average
Momentum 20
75.02% below the market average75.02% below the market average75.02% below the market average75.02% below the market average75.02% below the market average
69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
82.9% below the market average82.9% below the market average82.9% below the market average82.9% below the market average82.9% below the market average
51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
77.05% below the market average77.05% below the market average77.05% below the market average77.05% below the market average77.05% below the market average
40.74% below the sector average40.74% below the sector average40.74% below the sector average40.74% below the sector average40.74% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
47.94% below the market average47.94% below the market average47.94% below the market average47.94% below the market average47.94% below the market average
16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average
Cash
21.26% below the market average21.26% below the market average21.26% below the market average21.26% below the market average21.26% below the market average
7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
4.62% below the market average4.62% below the market average4.62% below the market average4.62% below the market average4.62% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
80.66% above the market average80.66% above the market average80.66% above the market average80.66% above the market average80.66% above the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 16.75p
Change Today -4.75p
% Change -22.09 %
52 Week High 82.00
52 Week Low 13.20
Volume 6,683,242
Shares Issued 95.31m
Market Cap £15.96m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average
58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average
Price Trend
78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
14:33 2,500 @ 16.77p
14:32 5,000 @ 16.93p
14:21 25,000 @ 16.94p
14:19 2,000 @ 17.00p
14:19 527 @ 16.50p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page